financetom
Business
financetom
/
Business
/
India Morning Newsletter, October 28
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India Morning Newsletter, October 28
Oct 27, 2025 8:38 PM

To access a PDF version of this newsletter, please click here

If you would like to receive this newsletter via email, please

register at:

https://solutions.lseg.com/MNCIndia-Subscriptionpage

For an index of our newsletters click on

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: McDonald's to Launch New Deals With Items Priced at $3 or Less
Market Chatter: McDonald's to Launch New Deals With Items Priced at $3 or Less
Mar 11, 2026
12:37 PM EDT, 03/11/2026 (MT Newswires) -- McDonald's (MCD) plans to launch new discounts and deals in April, including items for $3 and less and $4 breakfast meals, the Wall Street Journal reported Wednesday, citing people familiar with the matter. McDonald's didn't immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with...
SLB Sounds Alarm On Middle East Crisis, Warns Of Q1 Profit Hit
SLB Sounds Alarm On Middle East Crisis, Warns Of Q1 Profit Hit
Mar 11, 2026
SLB Ltd shares edged lower Wednesday after the oilfield services provider issued an update on its operations in the Middle East and warned of a potential impact on first-quarter results. The company said it continues to closely monitor the evolving situation in the region and is adjusting operations accordingly. “The safety and security of SLB’s employees is the highest priority,...
Regenxbio Reports 'Positive' Interim Data in Duchenne Trial
Regenxbio Reports 'Positive' Interim Data in Duchenne Trial
Mar 11, 2026
12:37 PM EDT, 03/11/2026 (MT Newswires) -- Regenxbio ( RGNX ) said Wednesday new interim results of its gene therapy RGX-202 study in Duchenne muscular dystrophy showed evidence of positively changing disease trajectory. The company said favorable safety profile continued with no serious adverse events or adverse events of special interest observed in the phase I/II study. The firm also...
Global dealmaking in oil and gas upstream was muted in 2025, Enverus says
Global dealmaking in oil and gas upstream was muted in 2025, Enverus says
Mar 11, 2026
March 11 (Reuters) - Dealmaking in the international upstream oil and gas market remained subdued for the second straight year in 2025, totaling just $18 billion, analytics firm Enverus said on Wednesday. Fewer high-quality resources and lower oil prices limited the value of mergers and acquisitions to well below the historical average of $60 billion, the firm said in a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved